Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17048 | 556 | 29.9 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
644 | 12881 | THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SOLUBLE INTERLEUKIN 2 RECEPTOR | Author keyword | 11 | 20% | 9% | 51 |
2 | SOLUBLE INTERLEUKIN 2 RECEPTOR SIL 2R | Author keyword | 8 | 50% | 2% | 11 |
3 | SOLUBLE INTERLEUKIN 2 RECEPTOR SIL2R | Author keyword | 4 | 75% | 1% | 3 |
4 | SERUM SOLUBLE INTERLEUKIN 2 RECEPTOR | Author keyword | 4 | 56% | 1% | 5 |
5 | SIL 2R | Author keyword | 4 | 18% | 4% | 20 |
6 | SOLUBLE CD8 | Author keyword | 3 | 27% | 2% | 10 |
7 | SCD8 | Author keyword | 3 | 31% | 1% | 8 |
8 | SERUM SIL 2R | Author keyword | 3 | 60% | 1% | 3 |
9 | SOLUBLE INTERLEUKIN 2 RECEPTORS | Author keyword | 3 | 29% | 1% | 8 |
10 | SOLUBLE INTERLEUKIN 2 RECEPTOR ALPHA | Author keyword | 2 | 44% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TAC ANTIGEN | 3 | 15% | 3% | 19 |
2 | BINDS INTERLEUKIN 2 | 3 | 28% | 1% | 8 |
3 | RECEPTOR LEVELS | 2 | 11% | 2% | 13 |
4 | ANTI TAC DACLIZUMAB | 1 | 100% | 0% | 2 |
5 | INCREASED CIRCULATING CONCENTRATIONS | 1 | 50% | 0% | 2 |
6 | INTERLEUKIN 2 RECEPTOR LEVELS | 1 | 14% | 1% | 7 |
7 | VIRUS INFECTED POPULATIONS | 1 | 33% | 0% | 2 |
8 | CHEMOKINE PATHWAYS | 1 | 50% | 0% | 1 |
9 | ELEVATED TITERS | 1 | 50% | 0% | 1 |
10 | LABORATORY CORRELATIONS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
THE SOLUBLE INTERLEUKIN-2 RECEPTOR - BIOLOGY, FUNCTION, AND CLINICAL-APPLICATION | 1990 | 481 | 83 | 43% |
On the role of sIL-2R measurements in rheumatoid arthritis and cancers | 2005 | 39 | 80 | 41% |
Serum soluble interleukin 2 receptor in human cancer of adults and children: a review | 2008 | 35 | 133 | 31% |
BIOLOGICAL SIGNIFICANCE OF SOLUBLE IL-2 RECEPTOR | 1993 | 73 | 161 | 39% |
Soluble cytokine receptors: Their roles in immunoregulation, disease, and therapy | 1996 | 60 | 312 | 17% |
THE SOLUBLE INTERLEUKIN-2 RECEPTOR AS A MARKER FOR HUMAN NEOPLASIA AND IMMUNE STATUS | 1991 | 33 | 70 | 40% |
SOLUBLE INTERLEUKIN-2 RECEPTORS - CLINICAL-VALUE AND BIOLOGICAL SIGNIFICANCE | 1991 | 3 | 25 | 68% |
Clinical significance of cytokine determination in synovial fluid | 2002 | 20 | 98 | 9% |
SERUM INTERLEUKIN-2 RECEPTOR - CLINICAL AND BIOLOGICAL IMPLICATIONS | 1989 | 38 | 59 | 27% |
SOLUBLE CYTOKINE RECEPTORS IN DISEASE | 1995 | 3 | 64 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN SURG GASTROENTEROL | 1 | 50% | 0.2% | 1 |
2 | DEVIS PATHOL | 1 | 50% | 0.2% | 1 |
3 | FAK MEDMED KLIN POLIKLIN | 1 | 50% | 0.2% | 1 |
4 | FOOD COMMODITIES SCI TECHNOL | 1 | 50% | 0.2% | 1 |
5 | INSERM U 702 | 1 | 50% | 0.2% | 1 |
6 | INTERNAL EXPT MED F MAGRASSI | 1 | 50% | 0.2% | 1 |
7 | LIFE MED SCI BONN LIMES | 1 | 50% | 0.2% | 1 |
8 | MACABBI MED SERV | 1 | 50% | 0.2% | 1 |
9 | RECETOX NAT SCI | 1 | 50% | 0.2% | 1 |
10 | CLIN IMMUNOPATHOL TRANSPLANTOL | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000231373 | INTERLEUKIN 2 RECEPTOR//IL 2 RECEPTOR//IL 2 RECEPTOR GAMMA CHAIN |
2 | 0.0000128073 | DERRIFORD COMBINED S//CYTOKINE GENE POLYMORPHISM//CLINICIZZATA CHIRURG 2 |
3 | 0.0000080396 | NEOPTERIN//7 8 DIHYDRONEOPTERIN//PTERIDINES |
4 | 0.0000066420 | CHAIR PEDIAT CARDIOL 2//SYNOVIAL MEMBRANES//CLIN GRP 3 |
5 | 0.0000060218 | NEW STERNHEIMER STAINING//GRAFT INFILTRATING CELLS//EX VIVO PROPAGATION |
6 | 0.0000059920 | SOLUBLE HLA//SOLUBLE HLA I//SOLUBLE HLA DR |
7 | 0.0000048627 | RETROVIROL EPIGENET//POLYANTIGENIC IMMUNOMODULATOR//V HA RAS ONCOGENE |
8 | 0.0000046622 | HAIRY CELL LEUKEMIA//HAIRY CELL LEUKAEMIA//HAIRY CELL LEUKEMIA VARIANT |
9 | 0.0000045208 | CYCLIC POLYLACTATE//RABDOMYOSARCOMA//CARCINOID SYNDROM |
10 | 0.0000044603 | WHOLE BLOOD CELL CULTURES//COLORIMETRY METHOD//HUMAN COLORECTAL TUMORS |